Clinical trial Recruiting at 7 sites Observational Ages 18 and up

Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

Official title: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System in a 'Real-World' Patient Population

Run by Sahajanand Medical Technologies Limited · NCT03443999 · Data updated 2026-11-12

This study is testing a new type of heart stent to see if it is safe and effective for people with coronary artery disease who need stents.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10000 (estimated)
SponsorSahajanand Medical Technologies Limited
Industry-sponsored
Locations7 sites (Breda, North Brabant and 6 other locations)
StatusRecruiting
StartedFebruary 27, 2018
Main results expectedJune 2027
Study endsDecember 2027
Registry record updatedApril 23, 2026
Trial IDNCT03443999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who require elective implantation of the Supraflex Family stent.

Probably not a fit

Patients who are pregnant, lactating, or have a high probability of non-adherence to follow-up requirements may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to assess the safety and efficacy of the Supraflex Family sirolimus-eluting coronary stent system in patients requiring stent implantation for coronary artery disease. It focuses on a new generation of drug-eluting stents that utilize a biodegradable polymer and a cobalt-chromium platform, which enhances flexibility and deliverability while maintaining strength. The study will collect data from a real-world patient population to evaluate the stent's performance in routine clinical practice.

Why it matters

Potential benefit: If successful, this study could provide insights into the long-term safety and effectiveness of a new stent technology for patients with coronary artery disease.

How similar studies have gone: Other studies have shown promise with biodegradable polymer stents, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. The patient, or legal representative, has been informed of the nature of the registry and has consented to participate and authorised the collection and release of his/her medical information by signing a Patient Informed Consent Form
3. Treating physician has electively implanted at least one Supraflex Family stent as part of the patient's planned clinical care.
4. The patient is willing and able to cooperate with study procedures and required follow up visits

Exclusion Criteria:

1. Women with known pregnancy or who are lactating
2. High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
3. Currently participating in another study that has not completed the primary endpoint or that clinically interferes with the current registry requirements
4. Planned surgery within 6-month of PCI unless dual anti-platelet therapy is maintained throughout the peri-surgical period

Where it's running

  • Amphia Ziekenhuis
    Breda, North Brabant, Netherlands
    Recruiting
  • Catharina Ziekenhuis
    Eindhoven, North Brabant, Netherlands
    Recruiting
  • Tergooi Ziekenhuis
    Blaricum, North Holland, Netherlands
    Recruiting
  • Medical Center Leeuwarden
    Leeuwarden, Provincie Friesland, Netherlands
    Recruiting
  • Albert Schweitzer Ziekenhuis
    Dordrecht, South Holland, Netherlands
    Recruiting
  • Maasstad Ziekenhuis
    Rotterdam, South Holland, Netherlands
    Recruiting
Show 1 more location
  • ZorgSaam Hospital
    Terneuzen, Zeeuws- Vlaanderen, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.